On July 1, 2015, the first Lipitor diabetes lawsuit trial is set to begin under guidelines of a multidistrict litigation. Lipitor is classified as a statin, a drug prescribed to reduce high cholesterol levels. More than 20 million people in the United States take statins to control their cholesterol.
In July 2013, an initial request to centralize various Lipitor lawsuits related to diabetes in women into a multidistrict litigation (MDL) was rejected ...
continue reading...